annual FCF:
$18.10B+$8.95B(+97.92%)Summary
- As of today (April 12, 2025), MRK annual free cash flow is $18.10 billion, with the most recent change of +$8.95 billion (+97.92%) on December 1, 2024.
- During the last 3 years, MRK annual FCF has risen by +$8.44 billion (+87.31%).
- MRK annual FCF is now at all-time high.
Performance
MRK Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$2.51B-$6.00B(-70.46%)Summary
- As of today (April 12, 2025), MRK quarterly free cash flow is $2.51 billion, with the most recent change of -$6.00 billion (-70.46%) on December 1, 2024.
- Over the past year, MRK quarterly FCF has stayed the same.
- MRK quarterly FCF is now -70.46% below its all-time high of $8.51 billion, reached on September 30, 2024.
Performance
MRK quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$18.10B+$3.26B(+21.94%)Summary
- As of today (April 12, 2025), MRK TTM free cash flow is $18.10 billion, with the most recent change of +$3.26 billion (+21.94%) on December 1, 2024.
- Over the past year, MRK TTM FCF has stayed the same.
- MRK TTM FCF is now at all-time high.
Performance
MRK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
MRK Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.9% | 0.0% | 0.0% |
| 3 y3 years | +87.3% | 0.0% | 0.0% |
| 5 y5 years | +79.7% | 0.0% | 0.0% |
MRK Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.9% | -70.5% | +438.2% | at high | +97.9% |
| 5 y | 5-year | at high | +210.7% | -70.5% | +438.2% | at high | +228.1% |
| alltime | all time | at high | +1809.5% | -70.5% | +199.5% | at high | +4367.1% |
Merck & Co Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.10B(+97.9%) | $2.51B(-70.5%) | $18.10B(+21.9%) |
| Sep 2024 | - | $8.51B(+75.6%) | $14.84B(+12.9%) |
| Jun 2024 | - | $4.85B(+117.4%) | $13.15B(+19.1%) |
| Mar 2024 | - | $2.23B(-400.0%) | $11.04B(+20.7%) |
| Dec 2023 | $9.14B(-37.8%) | -$743.00M(-110.9%) | $9.14B(-30.6%) |
| Sep 2023 | - | $6.82B(+148.8%) | $13.17B(+21.6%) |
| Jun 2023 | - | $2.74B(+725.0%) | $10.83B(-3.9%) |
| Mar 2023 | - | $332.00M(-89.9%) | $11.26B(-23.4%) |
| Dec 2022 | $14.71B(+52.2%) | $3.28B(-26.7%) | $14.71B(-3.6%) |
| Sep 2022 | - | $4.48B(+41.1%) | $15.25B(+5.9%) |
| Jun 2022 | - | $3.17B(-16.0%) | $14.40B(+13.1%) |
| Mar 2022 | - | $3.78B(-1.2%) | $12.73B(+31.8%) |
| Dec 2021 | $9.66B(+65.9%) | $3.82B(+5.5%) | $9.66B(+14.8%) |
| Sep 2021 | - | $3.63B(+141.0%) | $8.41B(+52.5%) |
| Jun 2021 | - | $1.50B(+112.1%) | $5.52B(-19.0%) |
| Mar 2021 | - | $709.00M(-72.5%) | $6.81B(+17.0%) |
| Dec 2020 | $5.82B(-42.2%) | $2.58B(+253.7%) | $5.82B(-16.9%) |
| Sep 2020 | - | $728.00M(-74.0%) | $7.01B(-26.6%) |
| Jun 2020 | - | $2.80B(-1103.6%) | $9.55B(+5.5%) |
| Mar 2020 | - | -$279.00M(-107.4%) | $9.05B(-10.1%) |
| Dec 2019 | $10.07B(+21.2%) | $3.76B(+15.1%) | $10.07B(+12.2%) |
| Sep 2019 | - | $3.27B(+41.9%) | $8.97B(+14.4%) |
| Jun 2019 | - | $2.30B(+210.7%) | $7.85B(-6.0%) |
| Mar 2019 | - | $741.00M(-72.2%) | $8.34B(+0.4%) |
| Dec 2018 | $8.31B(+82.1%) | $2.66B(+24.4%) | $8.31B(-7.2%) |
| Sep 2018 | - | $2.14B(-23.5%) | $8.95B(+72.2%) |
| Jun 2018 | - | $2.80B(+297.0%) | $5.20B(-2.3%) |
| Mar 2018 | - | $705.00M(-78.7%) | $5.32B(+16.6%) |
| Dec 2017 | $4.56B(-47.9%) | $3.30B(-305.0%) | $4.56B(+5.1%) |
| Sep 2017 | - | -$1.61B(-155.1%) | $4.34B(-49.0%) |
| Jun 2017 | - | $2.92B(-5617.0%) | $8.51B(+24.9%) |
| Mar 2017 | - | -$53.00M(-101.7%) | $6.82B(-22.2%) |
| Dec 2016 | $8.76B(-22.2%) | $3.08B(+20.3%) | $8.76B(-7.1%) |
| Sep 2016 | - | $2.56B(+109.1%) | $9.43B(-4.4%) |
| Jun 2016 | - | $1.23B(-35.3%) | $9.87B(-10.9%) |
| Mar 2016 | - | $1.89B(-49.5%) | $11.07B(-1.7%) |
| Dec 2015 | $11.26B(+98.4%) | $3.75B(+25.3%) | $11.26B(+126.1%) |
| Sep 2015 | - | $3.00B(+23.5%) | $4.98B(-17.2%) |
| Jun 2015 | - | $2.43B(+16.6%) | $6.01B(+7.4%) |
| Mar 2015 | - | $2.08B(-182.4%) | $5.60B(-1.3%) |
| Dec 2014 | $5.67B(-43.9%) | -$2.52B(-162.7%) | $5.67B(-47.5%) |
| Sep 2014 | - | $4.03B(+100.1%) | $10.79B(+4.2%) |
| Jun 2014 | - | $2.01B(-6.6%) | $10.36B(+0.9%) |
| Mar 2014 | - | $2.16B(-17.0%) | $10.27B(+1.6%) |
| Dec 2013 | $10.11B(+25.3%) | $2.60B(-27.7%) | $10.11B(+18.3%) |
| Sep 2013 | - | $3.59B(+86.7%) | $8.54B(+11.3%) |
| Jun 2013 | - | $1.93B(-3.3%) | $7.67B(-6.8%) |
| Mar 2013 | - | $1.99B(+93.0%) | $8.23B(+2.1%) |
| Dec 2012 | $8.07B(-24.3%) | $1.03B(-62.2%) | $8.07B(-16.5%) |
| Sep 2012 | - | $2.73B(+9.5%) | $9.67B(-12.8%) |
| Jun 2012 | - | $2.49B(+36.5%) | $11.09B(+0.0%) |
| Mar 2012 | - | $1.82B(-30.7%) | $11.09B(+4.0%) |
| Dec 2011 | $10.66B(+16.6%) | $2.63B(-36.6%) | $10.66B(-2.3%) |
| Sep 2011 | - | $4.15B(+66.7%) | $10.91B(+21.0%) |
| Jun 2011 | - | $2.49B(+78.0%) | $9.02B(-5.3%) |
| Mar 2011 | - | $1.40B(-51.5%) | $9.52B(+4.1%) |
| Dec 2010 | $9.14B(+373.5%) | $2.88B(+27.7%) | $9.14B(+15.0%) |
| Sep 2010 | - | $2.25B(-24.6%) | $7.95B(+56.5%) |
| Jun 2010 | - | $2.99B(+192.1%) | $5.08B(+105.2%) |
| Mar 2010 | - | $1.02B(-39.3%) | $2.48B(+28.2%) |
| Dec 2009 | $1.93B(-63.4%) | $1.69B(-373.8%) | $1.93B(+121.1%) |
| Sep 2009 | - | -$615.40M(-260.3%) | $873.30M(-69.5%) |
| Jun 2009 | - | $383.80M(-19.6%) | $2.86B(-19.8%) |
| Mar 2009 | - | $477.50M(-23.9%) | $3.56B(-32.4%) |
| Dec 2008 | $5.27B(-11.9%) | $627.40M(-54.2%) | $5.27B(-21.4%) |
| Sep 2008 | - | $1.37B(+25.8%) | $6.71B(-17.3%) |
| Jun 2008 | - | $1.09B(-50.2%) | $8.11B(-16.4%) |
| Mar 2008 | - | $2.19B(+6.0%) | $9.70B(+62.1%) |
| Dec 2007 | $5.99B | $2.06B(-25.6%) | $5.99B(+10.8%) |
| Sep 2007 | - | $2.77B(+3.4%) | $5.41B(+39.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $2.68B(-275.3%) | $3.89B(+23.6%) |
| Mar 2007 | - | -$1.53B(-203.3%) | $3.15B(-45.6%) |
| Dec 2006 | $5.79B(-6.8%) | $1.48B(+17.8%) | $5.79B(-6.1%) |
| Sep 2006 | - | $1.26B(-35.1%) | $6.16B(-9.4%) |
| Jun 2006 | - | $1.94B(+74.7%) | $6.80B(+7.6%) |
| Mar 2006 | - | $1.11B(-40.3%) | $6.32B(+1.8%) |
| Dec 2005 | $6.21B(-12.3%) | $1.86B(-1.9%) | $6.21B(+0.1%) |
| Sep 2005 | - | $1.89B(+29.9%) | $6.20B(+1.4%) |
| Jun 2005 | - | $1.46B(+46.3%) | $6.11B(-7.1%) |
| Mar 2005 | - | $996.20M(-46.2%) | $6.58B(-7.0%) |
| Dec 2004 | $7.07B(-11.0%) | $1.85B(+2.4%) | $7.07B(-5.8%) |
| Sep 2004 | - | $1.81B(-6.0%) | $7.51B(-14.8%) |
| Jun 2004 | - | $1.92B(+29.0%) | $8.82B(+9.5%) |
| Mar 2004 | - | $1.49B(-34.8%) | $8.05B(+1.3%) |
| Dec 2003 | $7.95B(+11.0%) | $2.29B(-26.6%) | $7.95B(+2.5%) |
| Sep 2003 | - | $3.12B(+169.0%) | $7.75B(+8.0%) |
| Jun 2003 | - | $1.16B(-16.5%) | $7.18B(+2.0%) |
| Mar 2003 | - | $1.39B(-33.6%) | $7.04B(-1.7%) |
| Dec 2002 | $7.16B(+20.5%) | $2.09B(-17.8%) | $7.16B(+4.8%) |
| Sep 2002 | - | $2.54B(+150.0%) | $6.83B(+4.5%) |
| Jun 2002 | - | $1.02B(-32.6%) | $6.54B(+10.6%) |
| Mar 2002 | - | $1.51B(-14.3%) | $5.91B(-0.5%) |
| Dec 2001 | $5.94B(+19.8%) | $1.76B(-21.7%) | $5.94B(+6.8%) |
| Sep 2001 | - | $2.25B(+473.6%) | $5.56B(+28.4%) |
| Jun 2001 | - | $392.10M(-74.5%) | $4.33B(-11.9%) |
| Mar 2001 | - | $1.54B(+11.3%) | $4.92B(-0.8%) |
| Dec 2000 | $4.96B(+38.9%) | $1.38B(+36.0%) | $4.96B(+21.1%) |
| Sep 2000 | - | $1.02B(+3.7%) | $4.10B(+2.9%) |
| Jun 2000 | - | $980.00M(-38.0%) | $3.98B(+8.8%) |
| Mar 2000 | - | $1.58B(+204.1%) | $3.66B(+2.5%) |
| Dec 1999 | $3.57B(+6.4%) | $519.50M(-42.3%) | $3.57B(-1.9%) |
| Sep 1999 | - | $900.40M(+36.7%) | $3.64B(-1.7%) |
| Jun 1999 | - | $658.70M(-55.8%) | $3.70B(+1.7%) |
| Mar 1999 | - | $1.49B(+153.7%) | $3.64B(+8.4%) |
| Dec 1998 | $3.35B(-31.1%) | $588.00M(-38.9%) | $3.35B(-21.3%) |
| Sep 1998 | - | $961.70M(+61.4%) | $4.26B(-6.1%) |
| Jun 1998 | - | $595.80M(-50.7%) | $4.54B(-6.3%) |
| Mar 1998 | - | $1.21B(-19.2%) | $4.85B(-0.5%) |
| Dec 1997 | $4.87B(+15.1%) | $1.50B(+20.9%) | $4.87B(-0.8%) |
| Sep 1997 | - | $1.24B(+37.2%) | $4.91B(+5.4%) |
| Jun 1997 | - | $902.00M(-26.8%) | $4.66B(+2.5%) |
| Mar 1997 | - | $1.23B(-19.9%) | $4.54B(+7.4%) |
| Dec 1996 | $4.23B(+118.2%) | $1.54B(+56.2%) | $4.23B(+20.7%) |
| Sep 1996 | - | $984.60M(+24.6%) | $3.50B(+9.1%) |
| Jun 1996 | - | $790.40M(-13.9%) | $3.21B(+21.5%) |
| Mar 1996 | - | $918.00M(+13.2%) | $2.64B(+36.3%) |
| Dec 1995 | $1.94B(-38.1%) | $811.20M(+17.1%) | $1.94B(+5.3%) |
| Sep 1995 | - | $692.60M(+212.8%) | $1.84B(-16.5%) |
| Jun 1995 | - | $221.40M(+3.7%) | $2.21B(-22.6%) |
| Mar 1995 | - | $213.50M(-70.1%) | $2.85B(-8.9%) |
| Dec 1994 | $3.13B(+53.8%) | $714.40M(-32.5%) | $3.13B(+4.0%) |
| Sep 1994 | - | $1.06B(+22.0%) | $3.01B(+10.2%) |
| Jun 1994 | - | $867.10M(+76.5%) | $2.73B(+33.6%) |
| Mar 1994 | - | $491.30M(-17.3%) | $2.04B(+0.4%) |
| Dec 1993 | $2.04B(+41.6%) | $593.90M(-23.8%) | $2.04B(+5.2%) |
| Sep 1993 | - | $779.90M(+335.2%) | $1.94B(+18.9%) |
| Jun 1993 | - | $179.20M(-62.9%) | $1.63B(+2.5%) |
| Mar 1993 | - | $482.80M(-2.1%) | $1.59B(+10.4%) |
| Dec 1992 | $1.44B(+3.3%) | $493.10M(+4.5%) | $1.44B(+8.0%) |
| Sep 1992 | - | $471.80M(+237.7%) | $1.33B(+0.1%) |
| Jun 1992 | - | $139.70M(-58.1%) | $1.33B(+5.4%) |
| Mar 1992 | - | $333.20M(-13.8%) | $1.26B(-9.4%) |
| Dec 1991 | $1.39B(+0.6%) | $386.60M(-17.8%) | $1.39B(+1.4%) |
| Sep 1991 | - | $470.10M(+557.5%) | $1.37B(+10.1%) |
| Jun 1991 | - | $71.50M(-84.6%) | $1.25B(-13.6%) |
| Mar 1991 | - | $464.30M(+26.2%) | $1.44B(+4.3%) |
| Dec 1990 | $1.38B(+46.1%) | $368.00M(+7.1%) | $1.38B(+36.2%) |
| Sep 1990 | - | $343.50M(+28.1%) | $1.02B(+51.0%) |
| Jun 1990 | - | $268.20M(-33.8%) | $673.30M(+66.2%) |
| Mar 1990 | - | $405.10M | $405.10M |
| Dec 1989 | $947.70M | - | - |
FAQ
- What is Merck & Co annual free cash flow?
- What is the all time high annual FCF for Merck & Co?
- What is Merck & Co annual FCF year-on-year change?
- What is Merck & Co quarterly free cash flow?
- What is the all time high quarterly FCF for Merck & Co?
- What is Merck & Co quarterly FCF year-on-year change?
- What is Merck & Co TTM free cash flow?
- What is the all time high TTM FCF for Merck & Co?
- What is Merck & Co TTM FCF year-on-year change?
What is Merck & Co annual free cash flow?
The current annual FCF of MRK is $18.10B
What is the all time high annual FCF for Merck & Co?
Merck & Co all-time high annual free cash flow is $18.10B
What is Merck & Co annual FCF year-on-year change?
Over the past year, MRK annual free cash flow has changed by +$8.95B (+97.92%)
What is Merck & Co quarterly free cash flow?
The current quarterly FCF of MRK is $2.51B
What is the all time high quarterly FCF for Merck & Co?
Merck & Co all-time high quarterly free cash flow is $8.51B
What is Merck & Co quarterly FCF year-on-year change?
Over the past year, MRK quarterly free cash flow has changed by $0.00 (0.00%)
What is Merck & Co TTM free cash flow?
The current TTM FCF of MRK is $18.10B
What is the all time high TTM FCF for Merck & Co?
Merck & Co all-time high TTM free cash flow is $18.10B
What is Merck & Co TTM FCF year-on-year change?
Over the past year, MRK TTM free cash flow has changed by $0.00 (0.00%)